Activity of Andrographolide and Its Derivatives on HPV16 Pseudovirus Infection and Viral Oncogene Expression in Cervical Carcinoma Cells

REFERENCES

• Chao WW and Lin BF: Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian). Chin Med 5, 17, 2010.
   PubMedGoogle Scholar
• Shi MD, Lin HH, Chiang TA, Tsai LY, Tsai SM, et al.: Andrographolide could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation of MMP-7 expression. Chem Biol Interact 180, 344–352, 2009.
   Google Scholar
• Shen YC, Chen CF, and Chiou WF: Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol 135, 399–406, 2002.
   PubMed Web of Science ®Google Scholar
• Shen YC, Chen CF, and Chiou WF: Suppression of rat neutrophil reactive oxygen species production and adhesion by the diterpenoid lactone andrographolide. Planta Med 66, 314–317, 2000.
   PubMed Web of Science ®Google Scholar
• Amroyan E, Gabrielian E, Panossian A, Wikman G, and Wagner H: Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine 6, 27–31, 1999.
   PubMed Web of Science ®Google Scholar
• Trivedi NP, Rawal UM, and Patel BP: Hepatoprotective effect of andrographolide against hexachlorocyclohexane-induced oxidative injury. Integr Cancer Ther 6, 271–280, 2007.
   PubMed Web of Science ®Google Scholar
• Chang RS, Ding L, Chen GQ, Pan QC, Zhao ZL, et al.: Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus. Proc Soc Exp Biol Med 197, 59–66, 1991.
   PubMed Web of Science ®Google Scholar
• Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, et al.: A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res 14, 333–338, 2000.
   PubMed Web of Science ®Google Scholar
• Matsuda T, Kuroyanagi M, Sugiyama S, Umehara K, Ueno A, et al.: Cell differentiation-inducing diterpenes from Andrographis paniculata Nees. Chem Pharm Bull (Tokyo) 42, 1216–1225, 1994.
   PubMed Web of Science ®Google Scholar
• Kumar RA, Sridevi K, Kumar NV, Nanduri S, and Rajagopal S: Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol 92, 291–295, 2004.
   PubMed Web of Science ®Google Scholar
• Shi MD, Lin HH, Lee YC, Chao JK, Lin RA, et al.: Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide. Chem Biol Interact 174, 201–210, 2008.
   PubMed Web of Science ®Google Scholar
• Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, et al.: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348, 518–527, 2003.
   PubMed Web of Science ®Google Scholar
• zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2, 342–350, 2002.
   PubMed Web of Science ®Google Scholar
• Howie HL, Katzenellenbogen RA, and Galloway DA: Papillomavirus E6 proteins. Virology 384, 324–334, 2009.
   PubMed Web of Science ®Google Scholar
• Scheffner M, Werness BA, Huibregtse JM, Levine AJ, and Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129–1136, 1990.
   PubMed Web of Science ®Google Scholar
• Scheffner M, Huibregtse JM, Vierstra RD, and Howley PM: The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495–505, 1993.
   PubMed Web of Science ®Google Scholar
• Stanley MA, Pett MR, and Coleman N: HPV: from infection to cancer. Biochem Soc Trans 35, 1456–1460, 2007.
   PubMed Web of Science ®Google Scholar
• Woodman CB, Collins SI, and Young LS: The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7, 11–22, 2007.
   PubMed Web of Science ®Google Scholar
• Aromdee C, Suebsasana S, Ekalaksananan T, Pientong C, and Thongchai S: Stage of action of naturally occurring andrographolides and their semisynthetic analogues against herpes simplex virus type 1 in vitro. Planta Med 77, 915–921, 2011.
   PubMed Web of Science ®Google Scholar
• Pientong C, Wongwarissara P, Ekalaksananan T, Swangphon P, Kleebkaow P, et al.: Association of human papillomavirus type 16 long control region mutation and cervical cancer. Virol J 10, 30, 2013.
   PubMed Web of Science ®Google Scholar
• Buck CB, Thompson CD, Pang YY, Lowy DR, and Schiller JT: Maturation of papillomavirus capsids. J Virol 79, 2839–2846, 2005.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim SY, Lim SJ, Kim JY, and Lee SJ: One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae. Protein Expr Purif 70, 68–74, 2010.
   PubMed Web of Science ®Google Scholar
• Pastrana DV, Buck CB, Pang YY, Thompson CD, Castle PE, et al.: Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 321, 205–216, 2004.
   PubMed Web of Science ®Google Scholar
• Mistry N, Drobni P, Naslund J, Sunkari VG, Jenssen H, et al.: The anti-papillomavirus activity of human and bovine lactoferricin. Antiviral Res 75, 258–265, 2007.
   PubMed Web of Science ®Google Scholar
• Wiart C, Kumar K, Yusof MY, Hamimah H, Fauzi ZM, et al.: Antiviral properties of ent-labdene diterpenes of Andrographis paniculata nees, inhibitors of herpes simplex virus type 1. Phytother Res 19, 1069–1070, 2005.
   PubMed Web of Science ®Google Scholar
• Drobni P, Naslund J, and Evander M: Lactoferrin inhibits human papillomavirus binding and uptake in vitro. Antiviral Res 64, 63–68, 2004.
   PubMed Web of Science ®Google Scholar
• Zhao F, He EQ, Wang L, and Liu K: Anti-tumor activities of andrographolide, a diterpene from Andrographis paniculata, by inducing apoptosis and inhibiting VEGF level. J Asian Nat Prod Res 10, 467–473, 2008.
   PubMed Web of Science ®Google Scholar
• Sukardiman H, Widyawaruyanti A, Sismindari, and Zaini NC: Apoptosis inducing effect of andrographolide on TD-47 human breast cancer cell line. Afr J Tradit Complement Altern Med 4, 345–351, 2007.
   PubMed Web of Science ®Google Scholar
• Cheung HY, Cheung SH, Li J, Cheung CS, Lai WP, et al.: Andrographolide isolated from Andrographis paniculata induces cell cycle arrest and mitochondrial-mediated apoptosis in human leukemic HL-60 cells. Planta Med 71, 1106–1111, 2005.
   PubMed Web of Science ®Google Scholar
• Yan J, Chen Y, He C, Yang ZZ, Lu C, et al.: Andrographolide induces cell cycle arrest and apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes. Cell Biol Toxicol 28, 47–56, 2012.
   PubMed Web of Science ®Google Scholar
• Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, et al.: A p53-dependent mouse spindle checkpoint. Science 267, 1353–1356, 1995.
   PubMed Web of Science ®Google Scholar
• Di Leonardo A, Khan SH, Linke SP, Greco V, Seidita G, et al.: DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Research 57, 1013–1019, 1997.
   PubMed Web of Science ®Google Scholar
• Lanni JS and Jacks T: Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Molecular and Cellular Biology 18, 1055–1064, 1998.
   PubMed Web of Science ®Google Scholar
• Li J, Cheung HY, Zhang Z, Chan GK, and Fong WF: Andrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 cells via alteration of reactive oxygen species. Eur J Pharmacol 568, 31–44, 2007.
   PubMed Web of Science ®Google Scholar